Articles & Video
Future Trends in Proteins To Fight COVID-19
The whitepaper presents new case studies exposing the growing opportunities in protein therapeutics to treat COVID-19.
Emerging Therapies Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the most exciting developments in emerging therapies with one simple registration.
80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months
How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.
Podcast: How to Create the Ultimate Bispecific
What goes into making the perfect bispecific? In our first Life Sciences podcast, we find out the best steps from Volker Schellenberger at Amunix.
The biggest breakthroughs in life sciences the last 10 years
CRISPR, CAR-T, immunotherapies, genome sequencing, AI - what is the biggest breakthrough in the life sciences in the last 10 years?
Strategies to Innovate the Production of Next Generation Bioconjugates
From developing ADCs to tumor-targeting, this whitepaper reviews the latest common challenges and novel strategies for producing bioconjugates.
Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER
This paper looks at how to foster racial, gender, geographical, neuro and cognitive diversity in the life sciences to achieve an inclusive culture built for innovation.
REPORT: Antibody Therapeutic Modalities 2020
Global research study into the development, targets, challenges and technologies of different antibody therapeutic modalities.
REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020
Diversity and Inclusion in Life Sciences 2020: Research analysis of how life sciences professionals around the world view representation of women and minorities in the industry, plus the importance of sustainability.
The role of COVID-19 antibody testing for employers
How can widespread COVID-19 antibody testing help reopen offices and how close are we to achieving it?
Looking to 2030 Report: The Future of the Global Life Sciences and Pharma Industry
This exclusive report looks at predictions for how the global life sciences and pharma industry will change over the coming decade.
COVID-19 antibody therapeutic development - WHITEPAPER
This paper evaluates the antibody therapies for COVID-19 currently in clinical trials and preclinical development.
COVID-19 Report: The Response to and Impacts on the Global Life Sciences Industry
COVID-19 Report: How is the life sciences industry developing a vaccine, treatment and testing for COVID-19 and what impact is it having on supply chain?
Antibody Engineering and Therapeutics Survey: Tell us your views
Take part in our huge antibody therapeutic modalities survey to be in with a chance of winning a free conference pass.
The Future of Antibody Engineering and Therapeutics - eBook Series
In the first of our Antibody Therapeutics eBook Series, we take an in-depth look at how the latest technologies and strategies are shaping the future of the industry.
Life Sciences in 2030 Survey: Complete to win a 2-day conference pass
We are a conducting a huge survey of life sciences professionals around the world on how the industry will look by 2030. Complete it here to get early access to the final report.
Next Gen protein drug challenges and the latest technologies to overcome them - WHITEPAPER
This whitepaper looks at the main challenges facing protein-based therapeutics and the innovative new technologies and methods are being used to overcome them.
Engineering strategies for TCR and CAR-T cell therapies - WHITEPAPER
Engineering strategies for TCR and CAR-T cell therapies - download this whitepaper exploring the latest developments.
Novel technologies and approaches for optimizing antibody discovery - WHITEPAPER
This whitepaper examines some of the latest advancements in methods and technologies innovating the discovery of antibodies.
47% of antibody engineering professionals using next generation sequencing
We take a deep dive into the data around the implementation of technology in antibody engineering and therapeutics from our recent industry survey.